Expert shares positive view on hepatitis C research

The outlook for hepatitis C research is good, said Dr. Donald Jensen, director of the University of Chicago’s Center for Liver Diseases, in this interview. Researchers are using the word “cure” when, previously, they would limit the discussion to a “sustained response,” he said. The university has formed HCV CURE, an organization of patients who are willing to share their experiences with treatment to raise awareness. Chicago Tribune (tiered subscription model) (1/30)